Richard A. Barasch - 24 Jul 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney in fact for Richard Barasch
Issuer symbol
TOI
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4
Filing time
28 Jul 2025, 21:08:48 UTC
Previous filing
20 Jun 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BARASCH RICHARD A Director C/O ONCOLOGY INSTITUTE, INC., 18000 STUDEBAKER RD. SUITE 800, CERRITOS /s/ Mark Hueppelsheuser, Attorney in fact for Richard Barasch 28 Jul 2025 0001076341

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Other $0 -287,756 -9.8% $0.000000 2,635,881 24 Jul 2025 By LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RAB Ventures (DFP) LLC ("RAB Ventures") distributed 287,756 shares to one of its members, Boro Partners Fund 1 ("Boro") in accordance with Boro's beneficial interest in RAB Ventures. The reporting person is a 10% beneficial owner of Boro, but disclaims investment control over Boro. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein.
F2 The distributed shares were owned by RAB Ventures, an entity controlled by the reporting person.